共 46 条
- [2] Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents [J]. GENES CHROMOSOMES & CANCER, 2001, 31 (01) : 33 - 41
- [6] Bloomfield CD, 1997, CANCER-AM CANCER SOC, V80, P2191
- [7] Bloomfield CD, 1998, CANCER RES, V58, P4173
- [9] Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms [J]. BLOOD, 2000, 95 (06) : 2138 - 2143
- [10] Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1405 - 1413